Circulating interleukins, coronary artery disease, ischemic stroke and atrial fibrillation: Connecting the dots between inflammation and cardiovascular disease

2020 ◽  
Vol 313 ◽  
pp. 105-107
Author(s):  
Nicola Riccardo Pugliese ◽  
Stefano Masi
Keyword(s):  
Atrial Fibrillation ◽  
Cardiovascular Disease ◽  
Coronary Artery Disease ◽  
Ischemic Stroke ◽  
Coronary Artery ◽  
Artery Disease ◽  
Connecting The Dots

scholarly journals Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Circulation ◽  
2021 ◽  
Author(s):  
Tiffany M. Powell-Wiley ◽  
Paul Poirier ◽  
Lora E. Burke ◽  
Jean-Pierre Després ◽  
Penny Gordon-Larsen ◽  
...  
Keyword(s):  
Risk Factors ◽  
Heart Failure ◽  
Atrial Fibrillation ◽  
Cardiovascular Disease ◽  
Coronary Artery Disease ◽  
Weight Loss ◽  
Coronary Artery ◽  
Disease Risk ◽  
Artery Disease ◽  
The Impact

The global obesity epidemic is well established, with increases in obesity prevalence for most countries since the 1980s. Obesity contributes directly to incident cardiovascular risk factors, including dyslipidemia, type 2 diabetes, hypertension, and sleep disorders. Obesity also leads to the development of cardiovascular disease and cardiovascular disease mortality independently of other cardiovascular risk factors. More recent data highlight abdominal obesity, as determined by waist circumference, as a cardiovascular disease risk marker that is independent of body mass index. There have also been significant advances in imaging modalities for characterizing body composition, including visceral adiposity. Studies that quantify fat depots, including ectopic fat, support excess visceral adiposity as an independent indicator of poor cardiovascular outcomes. Lifestyle modification and subsequent weight loss improve both metabolic syndrome and associated systemic inflammation and endothelial dysfunction. However, clinical trials of medical weight loss have not demonstrated a reduction in coronary artery disease rates. In contrast, prospective studies comparing patients undergoing bariatric surgery with nonsurgical patients with obesity have shown reduced coronary artery disease risk with surgery. In this statement, we summarize the impact of obesity on the diagnosis, clinical management, and outcomes of atherosclerotic cardiovascular disease, heart failure, and arrhythmias, especially sudden cardiac death and atrial fibrillation. In particular, we examine the influence of obesity on noninvasive and invasive diagnostic procedures for coronary artery disease. Moreover, we review the impact of obesity on cardiac function and outcomes related to heart failure with reduced and preserved ejection fraction. Finally, we describe the effects of lifestyle and surgical weight loss interventions on outcomes related to coronary artery disease, heart failure, and atrial fibrillation.

scholarly journals The impact of growth differentiation factor 15 on the risk of cardiovascular disease: evidence from Mendelian randomization study

2020 ◽  
Author(s):  
Zhuo Wang ◽  
Fangkun Yang ◽  
Menghuai Ma ◽  
Qinyi Bao ◽  
Jinlian Shen ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Atrial Fibrillation ◽  
Cardiovascular Disease ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Causal Relationship ◽  
Mendelian Randomization ◽  
Cardioembolic Stroke ◽  
Growth Differentiation Factor 15 ◽  
Artery Disease

Abstract Background: Growth differentiation factor 15(GDF-15) concentration is apparently associated with cardiovascular disease, but whether there is a causal relationship has not been testified. Methods: We utilized Mendelian randomization to assess the function of GDF-15 in incidence of cardiovascular disease. The single-nucleotide polymorphism- GDF-15 association evaluations came from meta-analysis of genome-wide association study (GWAS). Besides inverse-variance weighted, MR-Egger test and weighted median method were applied to examine sensitivity. Results: Based on the instruments, GDF-15 level linked to the increasing risk of cardioembolic stroke (OR 1.09 per SD increase, 95% CI 1.01, 1.19) , atrial fibrillation (OR 1.03 per SD increase, 95% CI 1.0, 1.06), coronary artery disease (OR 0.94 per SD increase, 95% CI 0.89, 0.99) and myocardial infarction (OR 0.94 per SD increase, 95% CI 0.90, 0.98). However, the significant causal relationship between GDF-15 and the other cardiovascular diseases was not found in our study. Conclusions: The result suggested that GDF-15 was causally associated with the risk of cardioembolic stroke,atrial fibrillation, coronary artery disease and myocardial infarction, providing us conceivable strategies to alleviate the burden of cardiovascular disease.

scholarly journals The impact of growth differentiation factor 15 on the risk of cardiovascular disease: evidence from Mendelian randomization study

2020 ◽  
Author(s):  
Zhuo Wang ◽  
Fangkun Yang ◽  
Menghuai Ma ◽  
Qinyi Bao ◽  
Jinlian Shen ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Atrial Fibrillation ◽  
Cardiovascular Disease ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Causal Relationship ◽  
Mendelian Randomization ◽  
Cardioembolic Stroke ◽  
Growth Differentiation Factor 15 ◽  
Artery Disease

Abstract Background: Growth differentiation factor 15(GDF-15) concentration is apparently associated with cardiovascular disease, but whether there is a causal relationship has not been testified. Methods: We utilized Mendelian randomization to assess the function of GDF-15 in incidence of cardiovascular disease. The single-nucleotide polymorphism- GDF-15 association evaluations came from meta-analysis of genome-wide association study (GWAS). Besides inverse-variance weighted, MR-Egger test and weighted median method were applied to examine sensitivity. Results: Based on the instruments, GDF-15 level linked to the increasing risk of cardioembolic stroke (1.06, OR 1.09 per SD increase, 95% CI 1.01, 1.19) , atrial fibrillation (OR 1.03 per SD increase, 95% CI 1.0, 1.06), coronary artery disease (OR 0.94 per SD increase, 95% CI 0.89, 0.99) and myocardial infarction (OR 0.94 per SD increase, 95% CI 0.90, 0.98). However, the significant causal relationship between GDF-15 and the other cardiovascular diseases was not found in our study. Conclusions: The result suggested that GDF-15 was causally associated with the risk of cardioembolic stroke,atrial fibrillation, coronary artery disease and myocardial infarction, providing us conceivable strategies to alleviate the burden of cardiovascular disease.

scholarly journals Association between gallstone disease and ischemic stroke in Korea

2021 ◽  
Vol 26 (4) ◽  
pp. 649-655
Author(s):  
Eun Sun Gill ◽  
Young Jin Jeong ◽  
Junyong Lee
Keyword(s):  
Risk Factors ◽  
Atrial Fibrillation ◽  
Coronary Artery Disease ◽  
Ischemic Stroke ◽  
Coronary Artery ◽  
Odds Ratio ◽  
Obstructive Coronary Artery Disease ◽  
Gallstone Disease ◽  
Smoking History ◽  
Artery Disease

Background & Objectives: In Korea, stroke incidence is projected to rise due to the rapid aging of the Korean population. Additionally, gallstone disease incidence is increasing in Korea, due to dietary and westernized lifestyle. In this cross-sectional study, we investigated the association between gallstone disease and ischemic stroke in Korea. Methods: We included 566 patients aged 40‒89 years who underwent abdominal ultrasound or abdominal computed tomography at the VHS Medical Center between January 2008 and December 2010. Patient records were reviewed for the presence of hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, obstructive coronary artery disease, and smoking history. The associations between risk factors, including gallstone disease, and ischemic stroke were analyzed using Pearson’s chi-square tests. Multiple logistic regression analysis was performed with age, sex, smoking history, hypertension, obstructive coronary artery disease, and atrial fibrillation as covariates. Results: Age, sex, hypertension, obstructive coronary artery disease, atrial fibrillation, and smoking history were identified as significant risk factors for ischemic stroke (p-value < 0.05). Gallstone disease demonstrated an unadjusted odds ratio for ischemic stroke of 2.171 (95% confidence interval, 1.264‒3.729); after adjustment for risk factors, the odds ratio was 2.015 (95% confidence interval, 1.151‒3.528). Conclusion: In Korean patients, gallstone disease and ischemic stroke are correlated. Despite an unclear causality, the risk for ischemic stroke is significantly increased in patients with gallstone disease, even after adjusting for various confounders. Clinicians should be aware of the possibility of ischemic stroke in patients with gallstone disease, and should manage and educate patients accordingly.

A cross-sectional study for risk factor model predictive for developing ischemic stroke: a clinical pharmacist’s approach

2021 ◽  
Author(s):  
Adel Sadeq ◽  
Asim Ahmed Elnour ◽  
Nadia Al Mazrouei ◽  
Mohamed Baraka
Keyword(s):  
Physical Activity ◽  
Risk Factors ◽  
Atrial Fibrillation ◽  
Coronary Artery Disease ◽  
Ischemic Stroke ◽  
Coronary Artery ◽  
Outcome Measure ◽  
Cross Sectional ◽  
History Of ◽  
Artery Disease

Abstract BackgroundThere is a paucity of studies in ischemic stroke in our region.Aim The aim of the current study was to delineate the potentially risk factors for the development of ischemic stroke. MethodsWe have conducted a cross-sectional hospital-based study that has enrolled 210 subjects. The subjects have had presented to the emergency department in a tertiary hospital at the United Arab Emirates. Subjects were diagnosed with ischemic stroke within 24 hours of presentation. Outcome measureThe main outcome measure was the development of ischemic stroke during indexed hospital visit.ResultsThe mean age was 47.5 ±3.2 with higher preponderance of males over females (60.9%) and 48.1% were ≥65 years. The final logistic regression model for the development of ischemic stroke contains seven variables. In descending order the seven predictive risk factors for the development of ischemic stroke were: hypertension (OR 6.1, CI 2.4-9.5; P =0.029), coronary artery disease (OR 4.2, 3.7-9.1; P =0.038), low physical activity (OR 4.2, CI 2.1-9.1; P =0.035), history of previous stroke (OR 4.1, 1.4-3.4; P =0.033), atrial fibrillation (OR 3.2, CI 2.6-8.2; P =0.017), family history of stroke (OR 3.1, 1.3-6.9; P =0.042) and diabetes mellitus (OR 2.7, CI 1.25-6.1; P =0.035). The specificity of the model was 54.2%, the sensitivity was 89.7%, and the overall accuracy was 77.3%.ConclusionIt is prudent to control the modifiable risk factors for the development of stroke such as hypertension, diabetes, atrial fibrillation, coronary artery disease and low physical activity.

Sign in / Sign up

Export Citation Format

Share Document